Actively Recruiting
ResVir Novel Technologies for Respiratory Virus Identification
Led by Portsmouth Hospitals NHS Trust · Updated on 2025-03-12
1000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating a new rapid pathogen identification technology called the Pictura Bio system to detect and differentiate respiratory viruses from nasal and throat swab samples. This proof of concept study aims to improve virus detection methods, which currently can be slow or limited in accuracy and cost. The study will recruit both adults and children suspected of having respiratory viral infections to better train the system's algorithms for accurate virus identification. Participants will have a nasal swab taken for the study in addition to routine clinical samples. The Pictura Bio system uses a microscope and computer algorithm to recognize fluorescent patterns from different viruses. The system is still learning and improving as it collects more data. The study will collect samples and data from up to 1000 patients at a hospital setting to train and test the system's performance. During the study, basic information such as age, gender, blood test results, treatment, and outcomes will be collected alongside swab samples. The swab results from the study will not be shared with participants or affect their clinical care. Researchers will track how accurately the system identifies viruses and monitor seasonal respiratory virus prevalence and antibiotic use. The study will continue collecting and analyzing data until early 2026, with findings shared publicly through journals and community presentations.
CONDITIONS
Brief Title
Novel Technologies for Respiratory Virus Identification
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provide informed consent (or parental/guardian consent where appropriate)
- Able to provide nasopharyngeal swab or aspirate samples
- Have clinical suspicion of a respiratory viral infection with symptoms such as runny nose, sneezing, nasal congestion, new cough, sore throat, headache, muscle aches, fever, or chills
You will not qualify if you...
- Unable to comply with study procedures or if a nasopharyngeal swab may be harmful
- Lacking capacity to provide consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 3 years until March 2026
Participants provide nasal and/or throat swab samples as part of their clinical assessment and additional nasal swabs for research purposes to help train and test the Pictura Bio system's ability to identify respiratory viruses.
1 visit (in-person) coinciding with clinical assessment
Duration - Up to 3 years until March 2026
Participants' data, including clinical information and outcomes, are securely collected to observe the accuracy and improvement of the Pictura Bio system over time without affecting patient care.
No additional visits; data collected from routine care
Trial Site Locations
Total: 1 location
1
Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital
Portsmouth, Hampshire, United Kingdom, PO6 3LY
Actively Recruiting
Research Team
Y
Yvette Hibberd
J
Joe Shoebridge
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here